Holy Stone Healthcare Co., Ltd.
Holy Stone Healthcare Co., Ltd. develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis, a product designed to relive pain and stiffness of the knee joint; SportVis, a treatment to relive the pain and optimize the recovery of tendon and ligament injuries; TRUD, a treatment that allows mucosal tissue to heal naturally and reduces the symptoms of ulce… Read more
Holy Stone Healthcare Co., Ltd. (4194) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.197x
Based on the latest financial reports, Holy Stone Healthcare Co., Ltd. (4194) has a cash flow conversion efficiency ratio of -0.197x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-49.38 Million) by net assets (NT$250.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Holy Stone Healthcare Co., Ltd. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Holy Stone Healthcare Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Holy Stone Healthcare Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Holy Stone Healthcare Co., Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Audax Renovables S.A.
MC:ADX
|
0.225x |
|
Natural Alternatives International
NASDAQ:NAII
|
-0.094x |
|
Samart Telcoms Public Company Limited
BK:SAMTEL
|
0.208x |
|
Hung Thinh Incons JSC
VN:HTN
|
N/A |
|
IT Link SA
LSE:0NC8
|
N/A |
|
IMPERO A/S DK -10
F:905
|
N/A |
|
Pure Hydrogen Corporation Limited
PINK:PHCLF
|
-0.039x |
|
Inversora Juramento SA
BA:INVJ
|
-0.033x |
Annual Cash Flow Conversion Efficiency for Holy Stone Healthcare Co., Ltd. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Holy Stone Healthcare Co., Ltd. from 2019 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$182.84 Million | NT$-109.13 Million | -0.597x | -23.04% |
| 2024-12-31 | NT$294.07 Million | NT$-142.66 Million | -0.485x | +85.42% |
| 2023-12-31 | NT$83.37 Million | NT$-277.29 Million | -3.326x | -1091.44% |
| 2022-12-31 | NT$522.74 Million | NT$-145.94 Million | -0.279x | +46.53% |
| 2021-12-31 | NT$264.07 Million | NT$-137.87 Million | -0.522x | -133.49% |
| 2020-12-31 | NT$451.27 Million | NT$-100.91 Million | -0.224x | +26.25% |
| 2019-12-31 | NT$655.64 Million | NT$-198.77 Million | -0.303x | -- |